+1-902-442-0653
Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street
Technology
Technology
Technology Overview
Therapies
Therapies Overview
Targeted Hyperthermia Therapy
Pre-Clinical Study
Whitepapers and Publications
The Giacomantonio Immuno-Oncology Research Group
Diagnostics
Diagnostics Overview
Concussion Tests
Bovine Tuberculosis Tests
Investors
Share Information
Investor Presentation
Financial Reports
News & Media
All News & Media
News Releases
Media Centre
About Us
Our Story
Leadership
Board of Directors
Advisory Board
Contact Us
Contact
Newsletter Subscribe
Subscribe
Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues
October 29, 2020
News Releases
Previous Article
Is Canada focused on the wrong COVID-19 tests?
Next Article
Sona Nanotech appoints new Director
You may also like
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results
Sona Nanotech Announces Filing of Provisional Patent Application
Technology
Technology
Technology Overview
Therapies
Therapies Overview
Targeted Hyperthermia Therapy
Pre-Clinical Study
Whitepapers and Publications
The Giacomantonio Immuno-Oncology Research Group
Diagnostics
Diagnostics Overview
Concussion Tests
Bovine Tuberculosis Tests
Investors
Share Information
Investor Presentation
Financial Reports
News & Media
All News & Media
News Releases
Media Centre
About Us
Our Story
Leadership
Board of Directors
Advisory Board
Contact Us
Contact
Newsletter Subscribe
Subscribe